Skip to content

Photobiomodulation Therapy (PBMT) for Accelerating Maxillary Canine Movement Using Two Wavelengths (650 nm and 976 nm): A Split-Mouth Randomized Controlled Clinical Trial

Photobiomodulation Therapy (PBMT) for Accelerating Maxillary Canine Movement Using Two Wavelengths (650 nm and 976 nm): A Split-Mouth Randomized Controlled Clinical Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07597304
Acronym
PBMT-CAN
Enrollment
40
Registered
2026-05-19
Start date
2025-05-05
Completion date
2026-03-20
Last updated
2026-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthodontic Treatment Acceleration, Photobiomodulation Therapy

Keywords

Photobiomodulation Therapy Low-Level Laser Therapy Orthodontics Canine Retraction Orthodontic Tooth Movement

Brief summary

movement using low-level laser therapy with different wavelengths. Participants will receive laser application during orthodontic treatment, and the rate of canine movement will be measured and compared between the study groups. The results may help determine whether low-level laser therapy can accelerate orthodontic tooth movement safely and effectively.

Detailed description

Photobiomodulation therapy (PBMT) has been proposed as a non-invasive adjunctive method to accelerate orthodontic tooth movement and reduce overall treatment duration. This split-mouth randomized clinical trial aims to evaluate and compare the effectiveness of two different laser wavelengths (650 nm and 976 nm) on the acceleration of maxillary canine movement during orthodontic treatment. Participants requiring bilateral maxillary first premolar extraction and canine retraction as part of their orthodontic treatment will be included. Each patient will serve as their own control using a split-mouth design. One side will receive PBMT application during canine retraction, while the contralateral side will act as the control or receive an alternative wavelength according to the randomization protocol. Orthodontic canine movement will be performed using standardized orthodontic mechanics under controlled force application. The primary outcome measure will be the rate of maxillary canine movement assessed at regular intervals. Secondary outcomes will include total treatment duration required for space closure and the influence of patient-related factors such as age and gender on treatment outcomes. The study will compare the clinical effectiveness of 650 nm and 976 nm wavelengths in accelerating orthodontic tooth movement. Statistical analyses including paired t-tests, independent t-tests, and correlation analyses will be used to evaluate differences between groups and assess associations between demographic variables and treatment response. The findings of this study may provide clinically relevant evidence regarding the effectiveness of PBMT in reducing orthodontic treatment time and improving treatment efficiency.

Interventions

DEVICE650 nm Photobiomodulation Therapy

Application of 650 nm low-level laser therapy during maxillary canine retraction to accelerate orthodontic tooth movement.

DEVICE976 nm Photobiomodulation Therapy

Application of 976 nm low-level laser therapy during maxillary canine retraction to accelerate orthodontic tooth movement.

Sponsors

Kufa University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Masking description

This is an open-label study in which both the investigator and participants are aware of the laser wavelength applied during treatment.

Intervention model description

This study uses a split-mouth randomized clinical trial design in which each participant serves as their own control. Maxillary canine retraction will be performed bilaterally following premolar extraction. Different photobiomodulation therapy wavelengths (650 nm and 976 nm) will be applied according to the randomization protocol during orthodontic canine movement.

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* good oral hygiene and the absence of any medications affecting bone metabolism.

Exclusion criteria

* systemic diseases, periodontal pathology, a history of previous orthodontic treatment, or the use of antibiotics or anti-inflammatory drugs during the study.\[

Design outcomes

Primary

MeasureTime frameDescription
Rate of Maxillary Canine Movement6 monthsMeasurement of the amount of maxillary canine movement during orthodontic retraction following application of photobiomodulation therapy using 650 nm and 976 nm wavelengths.

Secondary

MeasureTime frameDescription
Correlation Between Age and Rate of Canine Retraction6 monthsAssessment of the correlation between patient age (years) and rate of maxillary canine retraction measured in millimeters per month using digital caliper measurements on study models.
Difference in Rate of Canine Retraction Between Sexes6 monthsComparison of the rate of maxillary canine retraction (mm/month) between male and female participants measured using digital caliper measurements on study models.

Countries

Iraq

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 20, 2026